Janna Weber

Janna M. Weber supports the National Library of Medicine (NLM) within the National Institutes of Health in procuring specialized information technology and professional services critical to advancing biomedical data infrastructure. She manages acquisitions for digital systems that curate, organize, and disseminate scientific knowledge, including biomedical vocabularies, clinical trial registries, and public health information platforms. Her work ensures NLM’s mission to provide trusted, accessible resources to researchers, clinicians, and the public through robust, scalable IT solutions and analytical services. Weber typically handles complex, long-term contracts requiring deep technical expertise in data standards, interoperability, and secure information management. Her contractor relationships center on firms delivering high-integrity software development, data curation services, and laboratory instrumentation support. She engages with a mix of large technology integrators and specialized niche vendors capable of meeting NLM’s stringent requirements for data accuracy, compliance, and long-term system sustainability. While no single contractor dominates her portfolio, her procurement patterns reflect a preference for vendors with proven experience in biomedical informatics, ontology development, and health data standardization. Weber’s contracting approach is overwhelmingly non-set-aside, with over 95% of awards issued under full and open competition, reflecting the technical specificity and national importance of NLM’s mission-critical systems. Small business participation is modest but intentional, with approximately 3.6% of awards directed to total small business set-asides and a minimal share allocated to 8(a) competed contracts, indicating a focus on capability over socioeconomic preference. Her procurement focus is concentrated in analytical laboratory instrument manufacturing, biological product manufacturing, and testing laboratory services—domains essential to validating and supporting NLM’s data assets. She frequently acquires precision instrumentation for data generation, bioinformatics tools, and certified testing services that ensure the reliability of biomedical datasets underpinning public health research and clinical decision-making.